Alzheimer's Clinical Study
MEMORIES ARE WHAT MAKES US HUMAN
We are seeking individuals between the ages of 55-80 who have been diagnosed with Alzheimer’s Disease to participate in a clinical research study.
NeuroStar uses transcranial magnetic stimulation (TMS) to target key areas of the brain that are underactive in people with depression. It is not ECT (electroconvulsive therapy). While the exact cause of depression is not known, the leading scientific theory is that it is caused by an imbalance of the brain’s neurotransmitters, which are chemical messengers that send signals between brain cells.
During a NeuroStar treatment session, a magnet similar in strength to that used in a magnetic resonance imaging (MRI) machine is used to stimulate nerve cells in the area of the brain thought to control mood. These magnetic pulses may have a positive effect on the brain’s neurotransmitter levels, mak ing long-term remission possible.
With more than one million treatments performed, this novel treatment approach to achieving remission is bringing new hope to people every day.
NeuroStar® makes long-term remission possible. It’s safe and easy to tolerate, and has patented precision technology to ensure you receive the right dose to the right location, every time. It is the #1 TMS choice of doctors.
Stedman Clinical Trials offers professional recruitment, trial and administrative services across a variety of indications, with a central focus on psychological disorders and neuro-degenerative diseases such as Alzheimer’s. Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a research study.
MEMORIES ARE WHAT MAKES US HUMAN
We are seeking individuals between the ages of 55-80 who have been diagnosed with Alzheimer’s Disease to participate in a clinical research study.
YOU DON'T HAVE TO LIVE WITH LONELINESS
We are seeking individuals ages 18 and older who have been diagnosed with major depression, and are currently being treated with an antidepressant, to participate in a clinical research study.